S2Medical AB
Research S2Medical AB (S2M) on Bullrun: market cap SEK 4.35M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerS2M
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencySEK
- Market capSEK 4.35M
- Financial periodFY2025
- RevenueSEK 16.13M
- Revenue growth9.9%
- Net income-SEK 10.09M
- Free cash flowSEK 680.00K
- Gross margin87.0%
Valuation Snapshot
latest market cap is SEK 4.35M.
About S2Medical AB
S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery.
Frequently asked questions
What is S2Medical AB's market cap?
S2Medical AB's market capitalization is SEK 4.35M.
What does S2Medical AB do?
S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system;